Veteran video game developer Tomonobu Itagaki has passed away at the age of 58. Famous for his work on the Dead or Alive fighting game franchise and the revival of Ninja Gaiden in the 2000s, Itagaki's ...
October was rough for Aussie tech, with Xero and WiseTech dragging the XIJ down 8pc, but behind the red ink a new crop of ...
It is hard to believe that it is almost one year since the bridge lights first turned on in Montpelier. Since the joyful opening event on Nov. 16, seven illuminated bridges spanning the North Branch ...
More than 350,000 votes were cast in our annual hotly-contested ballot for the sexiest men of the year, and now we're ready to announce the winners Alex Apatoff is the Managing Editor, Special ...
An Indiana mother whose family feared she was kidnapped after she mysteriously vanished while their home was on fire was found over a week later in the woods, a few miles from the property. Britney ...
Tomonobu Itagaki, the legendary creator of the Dead or Alive series, and creative mind behind the 2004 version of Ninja Gaiden, has passed away at the age of 58. The news was shared on his personal ...
Tomonobu Itagaki — the flamboyant founder of developer Team Ninja, creator of fighting game series Dead or Alive, and director of the influential 2004 action game Ninja Gaiden — has died at the age of ...
The Athletics are hoping to make the jump from a 76-win team to a postseason contender in 2026, and with the ALCS kicking off last night, we thought it would be a good idea to see how the A's stacked ...
Tomonobu Itagaki, the influential video game designer known for Dead Or Alive and 2004’s Ninja Gaiden, has died. Rarely seen in public without his black sunglasses that gave the gaming auteur a ...
Three “very significant” new leads from the investigation into Amy Bradley, whose baffling 1998 disappearance from a Royal Caribbean cruise ship was the subject of a recent Netflix docuseries, suggest ...
The Blue Jays scored just four runs across the first two games of the American League Championship Series. Things turned around in a big way on Wednesday night as the series flipped to Seattle. The ...
Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to 27 months, keeping alive one of the last remaining hopes for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results